FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:1086-1088 October 20, 1994 Number 16 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Since coronary-artery bypass grafting was introduced by Favaloro in 1969,¹ its results have improved steadily even though the procedure has been performed increasingly in patients whose operative risk is relatively high because of advanced age, impaired left ventricular systolic performance, or extensive coronary artery disease.² The improvement has been due, at least in part, to the routine use of internal-thoracic-artery conduits³ and antiplatelet therapy,⁴ as well as better intraoperative protection of the heart. When the procedure is performed electively in patients at low risk, mortality is only about 1 percent.⁵

In randomized comparisons with medical therapy in patients with stable . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Huckman, R. S. (2003). The Utilization of Competing Technologies Within the Firm: Evidence from Cardiac Procedures. Management Science 49: 599-617 [Abstract]  
• Hartz, A. J., Kuhn, E. M., Doorey, A. J., Fischer, J. E., Leesar, M. A., Joseph, S. A., Prince, C. R., Hamm, C. W., Berger, J., Kalmar, P., King, S. B., Hillis, L. D., Rutherford, J. D. (1995). Coronary Angioplasty Compared with Bypass Grafting. NEJM 332: 888-890 [Full Text]